Mr. Capps brings to Indalo a track record of operational management, business development, and capital-raising success. He previously served as Director of Business Operations at Vasculox (now Arch Oncology) and as Director of Business Development at Mencuro Therapeutics. In all, he has contributed to the raising of well over $50 million in Seed and Series A funding for biopharmaceutical ventures. Prior to these operational roles, Mr. Capps provided management consulting services for biotechnology clients as part of the Strategy & Portfolio Analysis Practice of IMS Health. He received B.S. and M.S. degrees in the Biological Sciences and an M.B.A. from Stanford University.